REFERENCES Rashid Z, Khalil M, Khan MMM, et al
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
The following table breaks down key characteristics of various GLP-1 RAs, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, and Victoza, to give a clearer picture of their differences: This table elucidates the Ozempic vs Mounjaro debate, showing Mounjaros unique position with very high efficacy in both weight loss and blood sugar control
The 2-4 week window is not a hard cutoff
You may not have everything figured out, but you may know a few important things
The plastic in syringes can sometimes interact with the peptide solution over time, and theres a higher risk of contamination and loss of sterility